UCSF

ZINC00016154

Substance Information

In ZINC since Heavy atoms Benign functionality
July 23rd, 2004 22 Yes

CAS Numbers: 150812-12-7 , 150812-13-8 , [150812-12-7]

Other Names:

gab-

150812-12-7

150812-12-7; C13826; D-23129; N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester; Retigabine

150812-12-7; D09569; Ezogabine (USAN); Potiga (TN); Retigabine (INN)

2-Amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzene

AC-6908

AC1L3TLD

ADD-172014

ADD-230001

AW21-360

AWD-21360; D-23129; GKE-841; GW582892X; WAY-143841

AWD21-360

C101866

C13826

C16H18FN3O2

C16H18FN3O2; Carbamic acid, (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)-, ethyl ester; D 20443; D 23129; D-20443; D-23129; Ethyl (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)carbamate; Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate; LS-48932

Carbamic acid, (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)-, ethyl ester

CHEBI:161945

CHEMBL41355

CID121892

D 20443

D 23129

D-20443

D-23129

D-23129; Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate; N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester; N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester; ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate

D23129

DAP001422

Ethyl (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)carbamate

Ethyl (2-amino-4-((4-fluorobenzyl)amino)phenyl)carbamate dihydrochloride

Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate

ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride

ethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate

Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate

EZG

Ezogabine

Ezogabine (FDA

FT-0080801

GKE-841

GW-582892X

GW582892X

I06-0810

KE-0201

LS-191294

LS-48932

MFCD00912289

MFCD04307735

MolPort-003-850-148

N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester

N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester

N/A

N03AX21

nchembio874-comp3

Potiga

Retigabine Dihydrochloride

Retigabine hydrochloride

Retigabine [USAN]

RetigabineDihydrochloride

RTG

TL80090034

Trobalt

UNII-12G01I6BBU

USAN)

USAN); Retigabine (INN

USAN); Retigabine (INN)

WAY-143841

ZINC00016154

[2-Amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-carbamate

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.08 -2.41 -8.57 4 5 0 76 303.337 6

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 3.07e-02 g/l DrugBank-approved
Indications anticonvulsant KeyOrganics Bioactives

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
KCNQ2-1-E Voltage-gated Potassium Channel Subunit Kv7.2 (cluster #1 Of 1), Eukaryotic Eukaryotes 430 0.41 Binding ≤ 10μM
KCNQ3-1-E Voltage-gated Potassium Channel Subunit Kv7.3 (cluster #1 Of 1), Eukaryotic Eukaryotes 430 0.41 Binding ≤ 10μM
KCNQ2-1-E Voltage-gated Potassium Channel Subunit Kv7.2 (cluster #1 Of 1), Eukaryotic Eukaryotes 1300 0.37 Functional ≤ 10μM
Z80936-1-O HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other Other 1300 0.37 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
KCNQ2_HUMAN O43526 Voltage-gated Potassium Channel Subunit Kv7.2, Human 150 0.43 Binding ≤ 1μM
KCNQ3_HUMAN O43525 Voltage-gated Potassium Channel Subunit Kv7.3, Human 430 0.41 Binding ≤ 1μM
KCNQ2_HUMAN O43526 Voltage-gated Potassium Channel Subunit Kv7.2, Human 150 0.43 Binding ≤ 10μM
KCNQ3_HUMAN O43525 Voltage-gated Potassium Channel Subunit Kv7.3, Human 430 0.41 Binding ≤ 10μM
Z80936 Z80936 HEK293 (Embryonic Kidney Fibroblasts) 1300 0.37 Functional ≤ 10μM
KCNQ2_MOUSE Q9Z351 Voltage-gated Potassium Channel Subunit Kv7.2, Mouse 1300 0.37 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Interaction between L1 and Ankyrins
Voltage gated Potassium channels

Analogs ( Draw Identity 99% 90% 80% 70% )